Viewing Study NCT02145481



Ignite Creation Date: 2024-05-06 @ 2:52 AM
Last Modification Date: 2024-10-26 @ 11:24 AM
Study NCT ID: NCT02145481
Status: COMPLETED
Last Update Posted: 2018-12-04
First Post: 2014-05-15

Brief Title: Decisional Quality for Patients With Coronary Artery Disease
Sponsor: University of California San Francisco
Organization: University of California San Francisco

Study Overview

Official Title: Decisional Quality for Patients With Stable Coronary Artery Disease
Status: COMPLETED
Status Verified Date: 2018-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: DeQCAD
Brief Summary: The objective of the DeQCAD study is to measure the quality of the decision-making process for patients with coronary artery disease CAD and Acute Coronary Syndrome ACS who are making treatment decisions In particular this study is seeking to answer a How informed are patients about their treatment choices b are patients participating in the decision-making process as much as they would like to and c do the treatment decisions made match patients preferences
Detailed Description: For patients with coronary artery disease CAD having a stent or percutaneous coronary intervention or PCI involves both risk and inconvenience and thus it represents a classic preference-sensitive situation in which treatment decisions should be aligned with the patients preferences

In this project the investigators will develop the first comprehensive patient-reported measure of decisional quality for CAD that is feasible to implement in a variety of settings The investigators will accomplish this by 1 Identifying the key elements to capture decisional quality and identifying candidate questions to address these elements using patient and expert feedback 2 Pilot testing a preliminary instrument in a diverse patient population to assess measurement properties and select a reduced set of candidate questions for further testing and 3 Establish the reliability and validity of a new comprehensive decisional quality measure for single and repeated examinations This will result in a multidimensional decisional quality instrument for patients with CAD that will be ready for implementation into routine care

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None